Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RHOC | P08134 | 1/20 | 0.51 |
| ▸ | RHOA | P61586 | 1/20 | 0.51 |
| ▸ | EP300 | Q09472 | 6/20 | 0.51 |
| ▸ | CREBBP | Q92793 | 6/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845629 | 0.97 | TSHR (0.50) | RHOCRHOAEP300CREBBPTSHR | |
| SCHEMBL845290 | 0.91 | HCRTR1 (0.52) | TSHRSMN1; SMN2MAPK1ALDH1A1MAPT | |
| SCHEMBL845002 | 0.89 | CYP2C9 (0.55) | EP300CREBBPTSHRSMN1; SMN2MAPK1 | |
| SCHEMBL845539 | 0.87 | HCRTR1 (0.54) | EP300CREBBPTSHRSMN1; SMN2MAPK1 | |
| SCHEMBL845284 | 0.86 | MAPK1 (0.58) | EP300CREBBPMAPK1ALDH1A1ROCK2 | |
| SCHEMBL873856 | 0.83 | HCRTR1 (0.45) | TSHRSMN1; SMN2MAPK1ALDH1A1MAPT | |
| SCHEMBL873577 | 0.82 | LMNA (0.47) | EP300CREBBPTSHRSMN1; SMN2MAPK1 | |
| SCHEMBL13272181 | 0.82 | MAPK1 (0.53) | EP300CREBBPMAPK1ALDH1A1ROCK2 | |
| SCHEMBL845641 | 0.82 | MAPK1 (0.53) | EP300CREBBPMAPK1ALDH1A1ROCK2 | |
| SCHEMBL874313 | 0.78 | MAPK1 (0.50) | EP300CREBBPTSHRMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |